U.S. pharma giant copyright scrapped two experimental weight loss supplements final year—a when-every day pill, lotiglipron, as a result of elevated liver enzymes in addition to a two times-every day tablet, danuglipron, due to sturdy Unwanted side effects—but CEO Albert Bourla has s